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Background: Chronic localized pain syndromes, especially chronic low back pain (CLBP), are common reasons for
consultation in general practice. In some cases chronic localized pain syndromes can appear in combination with
chronic widespread pain (CWP). Numerous studies have shown a strong association between CWP and several
physical and psychological factors. These studies are population-based cross-sectional and do not allow for
assessing chronology. There are very few prospective studies that explore the predictors for the onset of CWP,
where the main focus is identifying risk factors for the CWP incidence. Until now there have been no studies
focusing on preventive factors keeping patients from developing CWP.
Our aim is to perform a cross sectional study on the epidemiology of CLBP and CWP in general practice and to
look for distinctive features regarding resources like resilience, self-efficacy and coping strategies. A subsequent
cohort study is designed to identify the risk and protective factors of pain generalization (development of CWP) in
primary care for CLBP patients.
Methods/Design: Fifty-nine general practitioners recruit consecutively, during a 5 month period, all patients who
are consulting their family doctor because of chronic low back pain (where the pain is lasted for 3 months).
Patients are asked to fill out a questionnaire on pain anamnesis, pain-perception, co-morbidities, therapy course,
medication, socio demographic data and psychosomatic symptoms. We assess resilience, coping resources, stress
management and self-efficacy as potential protective factors for pain generalization. Furthermore, we raise risk
factors for pain generalization like anxiety, depression, trauma and critical life events. During a twelve months follow
up period a cohort of CLBP patients without CWP will be screened on a regular basis (3 monthly) for pain
generalization (outcome: incident CWP).
Discussion: This cohort study will be the largest study which prospectively analyzes predictors for transition from
CLBP to CWP in primary care setting. In contrast to the typically researched risk factors, which increase the
probability of pain generalization, this study also focus intensively on protective factors, which decrease the
probability of pain generalization.* Correspondence: annika.viniol@staff.uni-marburg.de
1Department of General Practice/Family Medicine, University of Marburg,
Karl-von-Frisch-Str. 4, 35043 Marburg, Germany
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Self efficacyBackground
Chronic localized pain syndromes, especially chronic
low back pain (CLBP), are common reasons for consult-
ation in general practice. CLBP is usually defined as
pain, on most days of a three months period, in the back
area from underneath the costal margin to the gluteal
fold [1]. In some cases chronic localized pain syndromes
can appear in combination with chronic widespread pain
(CWP). Wolfe et al. defined CWP as pain in the left and
right side of the body as well as above and below the
waist plus pain in the axial skeleton [2]. A Swedish
cross-sectional-study found a CWP prevalence of 28%
out of all female CLBP patients in primary health care
[3]. It is still unclear whether CWP is a complication of
chronic local pain or an independent pain syndrome [4].
The association of CWP and several physical and psy-
chological factors are well-documented. Studies show
high prevalence of comorbidities [5] (most common are
anxiety and somatization disorders). CWP patients are
more often of older age, female, less educated and have
decreased health related quality of life [6]. They show
restricted functional ability [7] and frequently receive a
disability pension [8]. In addition, there is a high social
and economic burden of chronic pain, especially CWP
[9]. These studies are population-based cross-sectional
and cannot determine the temporal relationship between
predictors and the development of CWP (generalization
of pain). There are few prospective studies that explore
predictors for the onset of CWP. Gupta and colleagues
performed a population-based prospective study (EPI-
FUND-study) [10]. They identified the following disor-
ders to be associated with CWP: psychological distress
(in this case anxiety, depression, somatization disorders)
[10], health related quality of life [11], physical inactivity
[12], and sleep disorders [13].
Previous research, including the study of Gupta et al.,
primarily focused on risk factors (i.e., negative aspects
advancing the development of the disease and increasing
the probability of illness [14]). Our aim, on the other
hand, is to identify protective factors (predictors de-
creasing the probability of illness [14]). Our research ap-
proach has been derived from the salutogenetic concept
of Aaron Antonovsky [15]. His model of salutogenesis
focuses on factors enhancing health and wellbeing,
which protect (healthy) individuals from potentially
damaging influences. Resources like resilience, self-efficacy
and coping strategies are under consideration for beingprotective factors for incident chronic pain syn-
dromes. Costa et al. found a strong relationship be-
tween pain self-efficacy, pain intensity and disability in
patients with a recent onset of chronic low back pain
[16]. Another study by Ong et al. illustrated that psy-
chologically resilient individuals rebound from daily
pain catastrophizing through experiences of positive
emotions [17]. Finally, a study by Tan et al. studied
the relationship between coping, beliefs and the ad-
justment to chronic pain [18].
General practitioners (GP) are often the main coordi-
nators of CLBP and CWP patients’ management. They
provide longitudinal continuity of care and play a major
role with respect to appropriate care and health service
utilisation [19]. Therefore, epidemiological data and
knowledge about distinctive features between CLBP
patients and CWP patients is needed, especially for pri-
mary care setting. GPs need to have predictors to iden-
tify CLBP patients at risk of developing CWP.
Knowledge about protective factors will help to support
GPs in an individualized treatment approach.
Aim of the study
The aim of our study is to provide prevalence data on
CLBP and CWP for the primary care setting. The differ-
ences between both pain localizations, with respect to
pain characterisation and comorbidities, will be deter-
mined. In addition, we search for risk factors and pro-
tective factors of pain generalization in primary care
CLBP patients.
Methods/Design
Design overview
A 12 month cohort study is performed with baseline
data collection (T0) and four follow ups (after 3, 6, 9
and 12 months, T1-T4).
This project is part of the research Consortium
LOGIN “Localized and Generalized Muskuloskeletal
Pain: Psychobiological Mechanisms and Implications for
Treatment“ funded by the German Federal Ministry of
Education and Research.
Study population
For a multi centre data collection, general practitioners
in the State of Hessen, Germany are approached. Due to
logistical reasons, recruitment is conducted in four
waves. Participating practices (doctors and assistant
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consult for CLBP during a 5 months period, including
patients consulting in home visits and emergency calls.
Detailed inclusion and exclusion criteria are shown in
Table 1. Trained clinical monitors visit the practices to
insure validity and consecutive recruitment, during two
times (at beginning and at half time of recruitment
period).
The number of patients, who deny participation is
documented along with the reasons (in an anonymized
way), and these patients are accounted for our preva-
lence analyzes.
Data collection
A pen and paper questionnaire is used for data collec-
tion. After written consent is obtained, patients are
asked to fill in the first questionnaire. In addition, gen-
eral practitioners complete a case report form for every
participant. CLBP patients, having no CWP at baseline,
are included in the cohort study with a 12 months fol-
low up. They receive mailed follow up questionnaires
every three months (T1-T4), and if necessary, followed
by two telephone reminders. In cases where participants
are unreachable, we do ten calling attempts, during dif-
ferent day times before aborting the reminding process.
Participants, who do not return questionnaire and do
not explicitly refuse future participation, will be sent the
next questionnaire as scheduled.
Baseline measurements
For investigating distinctive features (e.g. pain character-
istics) between CLBP patients and CWP patients as well
as potential risk and protective factors, the following
physical and psychological parameters are collected at
baseline (Table 2):
Description of sample characteristics - pain characteristics
For pain localisations and consequently for definition of
CLBP and CWP we chose the body pain drawingTable 1 Inclusion- and exclusion criteria
Inclusion criteria All patients with chronic* low back pain** as a
primary or secondary consulting reason in
general practice.
*”chronic” was defined as pain during most days
in the last three months.
**”low back pain” means pain in the back area
under the costal arch, but over the bottom
fold (with or without pain radiation).
Exclusion criteria - patients under 18 years
- pregnant women
- persons with insufficient fluency of speaking
German language or dementia (subjective
impressed by doctor)model from Pfau et al. [20], where we modified the pic-
ture of the head and food. For definition of CWP, the
ACR criteria from Wolfe et al. are used [2]. To allow for
a standardized, objective analysis and classification we
developed an evaluation template according to Diesner
et al. [21] and Harkness [22].
We used the “German Pain Questionnaire” to deter-
mine the characteristics and history of the pain [23]. It is
the official pain questionnaire from the German Associ-
ation for the Study of Pain. The questions cover the fol-
lowing aspects: socio demographic data, subjective pain
description and perception, factors of pain alleviation
and exacerbation, disturbance as a result of pain, subject-
ive pain model, screening for depression and anxiety dis-
orders, health care utilization, as well as medical and
psychological comorbidities. Nagel et al. tested the feasi-
bility and content validity in a sample of 3000 patients
[24]. Comparison with external criteria (e.g. medical and
psychiatric-psychological diagnoses, physician-determined
chronicity of pain) showed good content validity and ex-
cellent reliability of patients statements [24]. For this
study we selected the following modules: pain duration,
-characteristics and –course, socio demographic data,
health care utilization and medication.
To assess the partner’s reaction in response to patient’s
pain, we use the social support subscale (3 items) of the
“West Haven-Yale Multidimensional Pain Inventory”
[25, 26]. It is a 12 scales questionnaire measuring the
impact of pain on a patient’s life, the responses of others
to the patients’ communications of pain and the extent
to which patients participate in common daily activities.
The reliability test of the German version (MPI-D)
from Flor et al. showed moderate to high internal
consistency of the different subscales (α= 0.63-0.90) [26].
For validation, every subscale was correlated with an ex-
ternal instrument showing moderate to high validity [26].
To classify subjective severity of chronic pain we use
the “Graded Chronic Pain” questionnaire (GCP)
according to von Korff [27]. The self-report measure
uses ratings of pain intensity and pain related disability.
The author suggests a hierarchical model of pain severity
where medium pain intensity is represented in the lower
range of pain severity, whereas measurements of intense
pain together with pain related disability are higher on
the scale [28]. This is a 7 item questionnaire resulting in
four hierarchical categories: Grade I, low disability - low
pain intensity; Grade II, low disability - high pain inten-
sity; Grade III, high disability - moderately limiting;
Grade IV, high disability - severely limiting. Grade III
and IV usually imply high pain intensity. According to
Klasen et al. [28], the German version of the GCP, the
factor 'Disability Score' showed a high internal
consistency (α= 0.88), whereas the internal consistency
of the factor 'Characteristic Pain Intensity' was moderate
Table 2 Overview of measurement instruments and time of assessment
CLBP + CWP CWP CLBP
Function Construct Type T0 T1 T1 T2 T3 T4
baseline 3 months 3 months 6 month 9 month 1 year
Description
of sample
characteristics
Socio demographic
data
German Pain Questionnaire
(module S)
+
Pain anamnesis Body pain drawing model + + + + + +
German Pain Questionnaire
(pain anamnesis)
+
Multidimensional Pain Inventory
(part 1, social support subscale)
+
Multidimensional Pain Inventory
(complete)
+
Graded Chronic Pain (von Korff Index) +
Pain perception Schmerzempfindungsskala (SES) + +
Therapy course +
medication
German Pain Questionnaire
(therapy and medication items)
+ + +
Comorbidities Self Administered Comorbidity
Questionnaire (SACQ)
+
Psychosomatic
symptoms
Symptom Check-List-90-R (SCL-90-R,
Somatisation subscale)
+
Risk factors Screening: anxiety
+ depression
Hospital Anxiety and Depression
Scale (HADS)
+
Trauma Screening Post Traumatic Diagnostic Scale
(PDS-d-1) (part 1 + 2)
+ +
Critical life events Questionnaire for critical life events + +
Protective factors Resilience Brief Resilience scale (RS-11) +
Coping resources
for back pain
Fragebogen zu Bewältigungsressourcen
bei Rückenschmerzen (FBR)
+
Stress Management Brief-Cope + +
Self-Efficacy GSE (General Self-Efficacy) + +
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of the German GCP and its subscales to other instru-
ments on the patient's disability (Funktionsfragebogen
Hannover: Spearman’s Rho =−0.34; Pain Disability
Index: Spearman’s Rho = 0.56) [28].
Description of sample characteristics - comorbidities
Comorbidities are assessed by the “Self Administered
Comorbidity Questionnaire” (SACQ) [29, 30]. Partici-
pants are asked to comment on 12 frequent medical
conditions (heart disease, high blood pressure, lung dis-
ease, diabetes, ulcer or stomach disease, kidney disease,
liver disease, anemia or other blood disease, cancer, de-
pression, arthritis, and back pain). For each medical con-
dition patients are asked whether they suffer from this
problem, if he/she receives treatment for it, and if the
problem causes functional limitations. The test-retest re-
liability for the SCQ was 0.94 (95% confidence interval:
0.72 to 0.99) as calculated by the intra class correlation
coefficient [29]. Regarding validity, the Spearman correl-
ation between the SACQ and the Charlson Index was
0.55 for the instrument [29].Description of sample characteristics - psychosomatic
symptoms
To identify psychosomatic symptoms, we use the
somatization subscale of the “Symptom Check-List-90-R”
(SCL-90-R) [31]. It is a commonly used psychological
status symptom inventory for mental illness. It is built
up of nine dimensions: somatization, obsessive compul-
sive, interpersonal sensitivity, depression, anxiety, anger/
hostility, phobic anxiety, paranoid ideation and psychoti-
cism. The instrument supports the computation of three
overall scales, comprising the number of symptoms in
general and their mean impact. Items are rated on the
5-point Likert Scale of distress, ranging from “not at all”
to “extremely”. Schmitz et al. described a high reliability
(internal consistency of somatization subscale α= 0.81)
and a moderate concurrent validity compared to the
“General Health Questionnaire” (0.52) [32].
Risk factor - anxiety and depression
The “Hospital Anxiety and Depression Scale” (HADS)
[33, 34] screens for anxiety disorders and depression. It
consists of two 7-item subscales (anxiety and depression).
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assesses symptoms in the last week. Psychometric prop-
erties of the HADS were assessed in numerous studies.
Herrmann et al. reported high reliability of the anxiety
and depression subscales (internal consistency anxiety
α= 0.80; depression α= 0.81) as well as high validity (cor-
related with external anxiety scales r = 0.65; depression
scales r = 0.70) of the German version of HADS [34].
Protective factor - coping resources for back pain
We use the FBR-questionnaire “Fragebogen zu Bewälti-
gungsressourcen bei Rückenschmerzen” from Tam-
cam et al. to assess coping resources for back pain [35].
It was specially developed for identifying helpful coping
resources of patients with back pain in primary care set-
ting. While other scales rather ask for the knowledge of
pain coping skills and resources, the 12-item-FBR expli-
citly asks for their perceived helpfulness [35]. Items are
rated on an eleven-point Likert scale ranging from “not
helpful” to “very helpful”.
Protective factor - resilience
Resilience as a potential protective factor towards pain
generalisation is estimated using the resilience scale
RS-11, a shortened and validated German form of the
Wagnild & Young questionnaire [36, 37]. It measures
the capacity to withstand life stressors. We use the 11-item
short version of the 25-item original scale. It consists of
two subscales (Personal Competence and Acceptance of
Self and Life). Reliability testing by Schumacher et al.
proved high internal consistence (α=0.91). In addition, val-
idity of RS-11 was demonstrated by a high correlation with
the construct of self-efficacy [37].
Supplementary baseline measurements for CWP patients
CLBP patients, having CWP at baseline, get supplemen-
tary concluding measurement instruments (SES, Brief
COPE, GSE, PDS-d-1, critical life events, apart from
therapy course, medication, MPI and body pain drawing
model), like the cohort group gets during follow ups.
Taking into account the length of the questionnaires
they are assessed after 3 months. An extensive descrip-
tion of the measurement instruments and our motiv-
ation for using it is described in the next chapter.
Follow up measurements for CLBP patients (cohort
group)
To identify incidental CWP (primary outcome), we col-
lected data every three months to screen for pain
generalization using the body pain drawing model
(T0-T4).
In addition the following physical and psychological
parameters are collected at follow up (Table 2):Description of sample characteristics - pain perception
We assess pain perception with the “Schmerzempfin-
dungsskala” (SES) during the first follow up [38]. The
questionnaire consists of 24 items with two global
dimensions “affective aspects of pain perception” and
“sensory aspects of pain perception”. The items ask for
different pain perceptions (for example: “My pain feels
hot.”) and patients have to judge their degree of agree-
ment on a four-point Likert scale ranging from “not true”
to “absolutely true”. Psychometric tests showed high reli-
ability (internal consistency of the affective subscale/sen-
sory subscale α= 0.92/α= 0.81) and good validity [38].
Description of sample characteristics - health care
utilization and medication
Just like at baseline, health care utilization and medi-
cation during the preceding half year are assessed after
the 6th and 12th month (T2 and T4).
During the 12 months follow up the following data
will be collected:
Protective factor - coping
To assess stress management competence (coping), we
use the Brief COPE from Carver et al. [39, 40]). It is a
shorter version of the original COPE questionnaire and
consists of 14 subscales, where each subscale is repre-
sented by two items. Participants are asked to think of
their usual thoughts and actions while faced with a diffi-
cult situation and to indicate their answers on a four-
point Likert-type scale, rating the resemblance of each
item to coping efforts pursued. The response scale
ranges from “not at all”, “a little bit”, “considerably” to
“very much”. Cooper et al. tested reliability of Brief
COPE to patients with Alzheimer’s disease. They
assessed average internal consistencies for emotion-
focused (α= 0.72), problem-focused (α= 0.84), and dys-
functional (α= 0.75) subscales [41]. Regression analyses
indicate convergent and concurrent validity [41].
Protective factor - self-efficacy
We use the “general self-efficacy-questionnaire” (GSE)
to assess self-efficacy [42, 43]. It applies to a patient’s
self-assessment of their ability to improve their daily
troubles and how they cope with critical situations. The
questionnaire consists of 10 items to be rated by four-
point-Likert-scale ranging from “very uncertain”, “rather
uncertain”, “rather certain” to “very certain”. Hintze
et al. showed a high reliability (internal consistency
α= 0.92) and good validity (correlation with the resili-
ence scale r = 0.68) of the German version of GSE [43].
Risk factor – trauma
We use Part 1 of the “Posttraumatic Diagnostic Scale”
(PTDS) [44] to assess whether patients suffer from
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ment based on the type, time duration, and circum-
stances of traumatic experiences [45]. Griesel et al.
reported high reliability (internal consistency of the total
scale was α= 0.94) and high validity (correlation with the
“Clinician Administered PTSD Scale” (CAPS) r = 0.76;
p = 0.001) of the German PTDS [45].
Risk factor - critical life events
The critical life events questionnaire from the work of
Leist et al. are used [46]. Participants are asked to select
if and when they experienced any possibly life changing
events on a 22 items list.
Description of sample characteristics - pain characteristics
Finally, during the fourth follow up measurement point
(T4) participants are asked to complete the “West
Haven-Yale Multidimensional Pain Inventory” [25,
26]. This is done to investigate if our CLBP patients can
be classified into the three clusters (dysfunctional, inter-
personally distressed, adaptive copers) that have been
widely shown to represent different subgroups of
patients with fibromyalgia [47].
General practitioners case report
GPs are asked to comment on the individual presence of
red flags with every patient included in the study. Red
flags are frequently used risk factors for identifying ser-
ious disorders causing low back pain [48]. In addition,
we ask GPs for their personal opinion about whether the
patient’s prognosis will be better, equal or worse in one
year. GPs are asked to estimate each patient’s probability
for pain generalization during the follow up.
Qualitative sub-study
Based on the results of the cohort study a qualitative
sub-study will be performed, after completed follow up,
regarding patients’ and physicians’ perspectives of a re-
source based treatment approach for prevention and
therapy of CLBP and CWP.
Statistical analysis
Group comparisons of CWP and CLBP patients will be
performed. For this we use measures of central tendency
(mean and standard deviation, median, percentile, fre-
quency and percentages) as well as chi-square tests for
categorical data. The t-test is applied for comparing
means. Effect sizes will be expressed in terms of odds
ratios for categorical dependent variables and, for quan-
titative dependent variables, in terms of group differ-
ences or differences per unit change of a quantitative
predictor variable.
For identification of predictors logistic regression ana-
lysis will be performed using incidental CWP asdependent variable. We use baseline risk and protective
factors as independent variables or predictors. All ana-
lyses are supervised and advised by a senior statistician
of the Institute of Genetic Epidemiology (IGE), Univer-
sity of Munich and Helmholtz Zentrum München.
Focus groups: The results of the focus groups are ana-
lyzed according to predefined main topics. Answers of
patients and physicians are contrasted.
Sample size
Based on results from previous studies we presumed a
CWP prevalence of 10% [49] leading to 900 patients to
be included in the cohort study (localized chronic pain
only). Assuming a 10% rate of patients developing gener-
alized pain (n = 90) [50] up to 9 independent variables
may be included in the logistic regression analysis (cor-
responding to 10 events per independent variable [51,
52]).
Power calculation
Assumptions: Prevalence of generalized chronic back
pain of 10%. A change of an independent variable by
one standard deviation in the population implies an odds
ratio of 1.65. Calculated power: 0.83 for alpha = 0.005,
which means after adjustment of multiple testing of 9–
10 variables an overall probability of the type one error
of 0.05 will not be exceeded. The power has been calcu-
lated by performing simulations using the software R
(R Development Core Team 2010).
Ethics committee
The study was approved by the local ethics commission
of Philipps-University Marburg (Ethik: 11.06.2010, AZ
88/10) and is in accordance with the Declaration of
Helsinki.
Discussion
This cohort study will be the largest study which pro-
spectively analyzes predictors for transition from CLBP
to CWP in primary care setting. In contrast to the typic-
ally researched risk factors, which increase the probabil-
ity of pain generalization, this study also focus
intensively on protective factors, which decrease the
probability of pain generalization. The identified risk and
protective factors might aloud GPs to identify patients at
risk for development of CWP. Furthermore, the acquired
knowledge about protective factors will help us to de-
velop an individualized treatment approach for GPs.
Selection bias is often the major limitation of a cohort
study. The amount of psychological constructs measured
in this study can be rather demanding in terms of endur-
ance and intellectual abilities compared to usual studies
in primary care setting. For our primary care study
population, which includes a high proportion of older
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it may be a problem to deal with the questionnaires.
These patients might be more likely to deny participa-
tion or abort follow up.
It might be possible, that GPs are more likely to re-
member study recruitment, in special cases (e.g. patients
with higher disease severity or special characters) or dur-
ing times with a lower workload. An incomplete recruit-
ment brings forth the risk of selection bias and lowers
external validity.
Results of the baseline analysis are expected in the
course of this year (2012). Follow up data will be com-
pleted, next year (2013).
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